Surgical Heart Valve Market Size, Share & COVID-19 Impact Analysis | Global | 2021-2027 | MedCore | Segmented by: Mechanical Heart Valve Market, Tissue Heart Valve Replacement Market and Annuloplasty Repair Device Market

  • Year: 2021
  • Scope: 10 Years
  • Region: Global
  • Type: MedCore

Product Description

The surgical heart valve market includes two sub-markets, the tissue heart valve, and the mechanical heart valve markets. The global tissue heart valve market size is estimated to increase over the forecast period to exceed $1.2 billion by 2027. The global mechanical heart valve market size is projected to reach $153.6 million by 2027. Lastly, the global annuloplasty repair device market is expected to increase over the forecast period to reach $246.9 million by 2027.

Edwards Lifesciences, Medtronic, and Abbott were the share leaders in the global tissue heart valve market. This global analysis covers over 70 countries, includes in-depth procedure numbers by country, and is segmented into the stented tissue heart valve market, the sutureless/rapid deployment tissue heart valve market, and the stentless tissue heart valve market. A driver of growth in the tissue heart valve market is the advent of advanced technologies such as sutureless/rapid deployment valves.

Abbott, Cryolife, and Sorin were the share leaders in the global mechanical heart valve market. This global analysis covers over 70 countries, and in-depth procedure numbers by country including the aortic, mitral, pulmonary, and tricuspid mechanical heart valve procedures. The main benefit of mechanical heart valves over tissue valves is their high durability, often lasting beyond the lifetime of the patient.

Edwards Lifesciences, Medtronic, and LivaNova were the share leaders in the global annuloplasty repair device market. This global analysis covers over 70 countries, and in-depth procedure numbers by country including the mitral, and tricuspid mechanical annuloplasty repair procedures. Annuloplasty repair procedures are most common in the population of patients over age 65. As the global population ages, the market is set to grow over the forecast period.


  • Unit Sales, Average Selling Prices, Market Size & Growth Trends
  • Procedure Numbers
  • COVID-19 Impact Analysis
  • Market Drivers & Limiters
  • Market Forecasts Until 2027, and Historical Data to 2017
  • Recent Mergers & Acquisitions
  • Disease Overviews
  • Company Profiles, Product Portfolios, and SWOT for Top Competitors

Procedure Numbers

procedure numbers by country for mechanical and tissue heart valves including the aortic, mitral, pulmonary, and tricuspid procedures

Procedure numbers for the surgical heart valve market include mechanical heart valves, tissue heart valves, and annuloplasty repair. For all three, the procedure numbers are divided by country with an in-depth analysis including information ranging from 2017 to 2027. The mechanical heart valve procedure numbers are further broken down per procedure including the aortic, mitral, pulmonary, and tricuspid procedures. The annuloplasty repair procedure numbers are further broken down per procedure including the mitral, and tricuspid procedures.

Tissue Heart Valve Market Insights

Growth within this market is primarily driven by unit sales which are powered by the continued shift in preference for tissue heart valves over the mechanical options. Overall, the market will experience slight growth over the forecast period as sutureless heart valve procedures and advancements increase and the elderly population expands. Tissue heart valves have an advantage over mechanical heart valves as they do not require the patient to take anti-coagulants, evidently making it the more popular option. tissue heart valve market global growth by segment from 2017-2027

Mechanical Heart Valve Market Insights

The mechanical heart valve market was led by aortic procedures in 2020. Growth, however, will not occur as this market is currently decreasing over the forecast period. These heart valves were rarely used to replace the tricuspid or pulmonary valves, and as a result, unit sales are decreasing. The largest limiter within this market is the need for anticoagulant therapy for the remainder of the patient’s life after the procedure. Despite this, advancements in technology surrounding the development of biocompatible polymers to reduce the formation of blood clots are underway. Patients would no longer need to use anti-coagulants and because of this, the market could experience growth.mechanical heart valve global market growth from 2017-2027

Annuloplasty Repair Device Market Insights

Annuloplasty repair procedures are the most common among patients over the age of 65. Therefore, growth within this market will increase as the proportion of the global population over the age of 65 increases. As a result of this, unit sales will increase along with the increasing population age and will allow the market to consequently increase at a modest rate. Along with this, advancements in minimally invasive repair procedures are being made which will improve patient outcomes and help fuel the growth of the repair market. In terms of limiters, the popular transcatheter heart valve repair procedure is rapidly growing and taking demand away from annuloplasty procedures. annuloplasty repair device global market growth from 2017-2027


The global surgical heart valve market is controlled by Edwards Lifesciences, Medtronic, Abbott, Cryolife, Sorin, and LivaNova. top competitors in the tissue, mechanical heart vale and annuloplasty device marketIn 2020, Edwards Lifesciences was the leader in the tissue heart valve market, capturing over 50% of the global market share. This company was also the leader in the annuloplasty repair device market. In 2020, Abbott was the leading competitor in the mechanical heart valve market. In the past, St. Jude Medical had previously controlled a larger share of the market; however, as Abbott has focused on other valve types, other companies have obtained some of its shares.


Throughout this report, iData Research has covered over 70 countries across the globe in great detail. Each global region may be purchased as a stand-alone report, tailoring the data to your needs. The regions covered are:

  • North America (the United States and Canada)
  • Latin America (Brazil, Mexico, Colombia, Argentina, Peru, Chile, Venezuela, and Other)
  • Western Europe (Germany, France, Italy, Spain, Switzerland, Austria, Portugal, Benelux, Scandinavia, and Other)
  • Central and Eastern Europe (Poland, Turkey, Russia, Greece, Czech Republic, Croatia, Bulgaria, Ukraine, Kazakhstan, Hungary, Romania, Baltic States (Estonia, Latvia, and Lithuania), and Other)
  • Middle East (Saudi Arabia, UAE, Israel, Iran, Kuwait, Qatar, Bahrain, Oman, and Other)
  • Asia Pacific (China, Japan, South Korea, India, Australia, Singapore, Indonesia, Malaysia, Thailand, the Philippines, Brunei, Myanmar, Cambodia, Vietnam, New Zealand, Taiwan, Hong Kong, and Other)
  • Africa South Africa, Egypt, Morocco, Ghana, Nigeria, Libya, Sudan, Uganda, Kenya, and Other)


FREE Sample Report

For a detailed table of contents, please contact an iData Research Product Advisor.
Companies Included: Abbott, CryoLife, LivaNova, Medtronic, Edwards Lifesciences, LifeNet Health, Others

iData’s 9-Step Research Methodology

Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Explore Options

Report Summary


Select License Type

Surgical heart valve replacement procedures can be performed using tissue or mechanical heart valves. Tissue valve procedures can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary), by material (xenograft or allograft) or device type (stented, sutureless or stentless). Mechanical valves can be classified by valve replaced (aortic, mitral, tricuspid or pulmonary) or by conduit (with conduit or without conduit).

  • 2021
  • 10 Years
  • Global
  • MedCore
    Your Cart
    Your cart is emptyReturn to Report Library